These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9412659)

  • 21. Do we have clarity on the therapeutic levels of morphine and its metabolites: seeking answers for the dilemma?
    Srinivas NR
    J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):163-6. PubMed ID: 23789848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.
    Hasselström J; Säwe J
    Clin Pharmacokinet; 1993 Apr; 24(4):344-54. PubMed ID: 8491060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of analgesic activity of morphine-6-glucuronide after short-term intravenous administration in healthy volunteers.
    Lötsch J; Kobal G; Stockmann A; Brune K; Geisslinger G
    Anesthesiology; 1997 Dec; 87(6):1348-58. PubMed ID: 9416720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone.
    Collins JJ; Geake J; Grier HE; Houck CS; Thaler HT; Weinstein HJ; Twum-Danso NY; Berde CB
    J Pediatr; 1996 Nov; 129(5):722-8. PubMed ID: 8917240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition and analgesic effects of systemic morphine, morphine-6-glucuronide and normorphine in rat.
    Hasselström J; Svensson JO; Säwe J; Wiesenfeld-Hallin Z; Yue QY; Xu XJ
    Pharmacol Toxicol; 1996 Jul; 79(1):40-6. PubMed ID: 8841095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-performance liquid chromatography-mass spectrometry-mass spectrometry analysis of morphine and morphine metabolites and its application to a pharmacokinetic study in male Sprague-Dawley rats.
    Zheng M; McErlane KM; Ong MC
    J Pharm Biomed Anal; 1998 Feb; 16(6):971-80. PubMed ID: 9547700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The oral-to-intravenous equianalgesic ratio of morphine based on plasma concentrations of morphine and metabolites in advanced cancer patients receiving chronic morphine treatment.
    Takahashi M; Ohara T; Yamanaka H; Shimada A; Nakaho T; Makoto Y
    Palliat Med; 2003 Dec; 17(8):673-8. PubMed ID: 14694918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model.
    Staahl C; Upton R; Foster DJ; Christrup LL; Kristensen K; Hansen SH; Arendt-Nielsen L; Drewes AM
    J Clin Pharmacol; 2008 May; 48(5):619-31. PubMed ID: 18440921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.
    Klimas R; Mikus G
    Br J Anaesth; 2014 Dec; 113(6):935-44. PubMed ID: 24985077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide.
    Osborne R; Joel S; Trew D; Slevin M
    Clin Pharmacol Ther; 1990 Jan; 47(1):12-9. PubMed ID: 2295214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary pharmacokinetics of morphine and its major metabolites following intravenous administration of four doses to horses.
    Knych HK; Steffey EP; McKemie DS
    J Vet Pharmacol Ther; 2014 Aug; 37(4):374-81. PubMed ID: 24479785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide.
    Penson RT; Joel SP; Roberts M; Gloyne A; Beckwith S; Slevin ML
    Br J Clin Pharmacol; 2002 Apr; 53(4):347-54. PubMed ID: 11966664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients.
    Wolff T; Samuelsson H; Hedner T
    Pain; 1996 Dec; 68(2-3):209-16. PubMed ID: 9121807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain.
    Gourlay GK; Cherry DA; Onley MM; Tordoff SG; Conn DA; Hood GM; Plummer JL
    Pain; 1997 Feb; 69(3):295-302. PubMed ID: 9085304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial.
    Narabayashi M; Saijo Y; Takenoshita S; Chida M; Shimoyama N; Miura T; Tani K; Nishimura K; Onozawa Y; Hosokawa T; Kamoto T; Tsushima T;
    Jpn J Clin Oncol; 2008 Apr; 38(4):296-304. PubMed ID: 18326541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphine and metabolites plasma levels after administration of sustained release morphine in Roux-en-Y gastric bypass subjects versus matched control subjects.
    Hachon L; Reis R; Labat L; Poitou C; Jacob A; Declèves X; Lloret-Linares C
    Surg Obes Relat Dis; 2017 Nov; 13(11):1869-1874. PubMed ID: 28864105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphine inhalation by cancer patients: a comparison of different nebulization techniques using pharmacokinetic, spirometric, and gasometric parameters.
    Krajnik M; Podolec Z; Siekierka M; Sykutera M; Pufal E; Sobanski P; Makarewicz R; Neef C; Punt N; Zylicz Z
    J Pain Symptom Manage; 2009 Nov; 38(5):747-57. PubMed ID: 19783397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of effect of ondansetron on the pharmacokinetics and analgesic effects of morphine and metabolites after single-dose morphine administration in healthy volunteers.
    Crews KR; Murthy BP; Hussey EK; Passannante AN; Palmer JL; Maixner W; Brouwer KL
    Br J Clin Pharmacol; 2001 Apr; 51(4):309-16. PubMed ID: 11318765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain.
    Portenoy RK; Sciberras A; Eliot L; Loewen G; Butler J; Devane J
    J Pain Symptom Manage; 2002 Apr; 23(4):292-300. PubMed ID: 11997198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine.
    van Dongen RT; Crul BJ; Koopman-Kimenai PM; Vree TB
    Br J Clin Pharmacol; 1994 Sep; 38(3):271-3. PubMed ID: 7826830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.